PRECISION BIOSCIENCES INC Current Liabilities
PRECISION BIOSCIENCES INC (DTIL) had Current Liabilities of $7.14 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $7.14M.
- 2026-03-31: Liabilities, Current $7.75M.
- 2025-12-31: Liabilities, Current $8.91M.
- 2025-09-30: Liabilities, Current $15.00M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $7.14M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $7.75M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $8.91M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $15.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $13.57M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $12.39M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $14.98M 10-K · filed 2026-03-12 |
| 2024-09-30 | $11.98M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $32.96M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $33.34M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $49.99M 10-K · filed 2025-03-26 |
| 2023-09-30 | $50.62M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $56.40M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $46.86M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $59.66M 10-K · filed 2024-03-27 |
| 2022-09-30 | $61.15M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $53.92M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $29.11M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $35.98M 10-K · filed 2023-03-09 |
| 2021-09-30 | $36.48M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $36.25M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $63.80M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $42.83M 10-K · filed 2022-03-15 |
| 2020-09-30 | $41.98M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $34.31M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $23.76M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $26.93M 10-K · filed 2021-03-18 |
| 2019-09-30 | $23.73M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $15.82M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $71.38M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $14.07M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |